# Hyperfine Receives CE and UKCA Marks for Next-Generation Swoop® System and Latest Advancement in Optive AI™ Software
Canonical URL: https://biopharmsignal.com/news/HYPR/hyperfine-receives-ce-and-ukca-marks-for-next-generation-swoopr-system-and-latest-advancement-in-optive-aitm-software
Ticker: HYPR
Company: Hyperfine
Source: Hyperfine
Published: 2026-04-09 12:15 EST
Original Source URL: https://investors.hyperfine.io
## Summary

This milestone unlocks Hyperfine’s most significant technology innovations to date for clinicians and patients across Europe and the United Kingdom, delivering a transformative leap in image quality and a major expansion of clinical capability for European markets GUILFORD, Conn.

## Article Body
This milestone unlocks Hyperfine’s most significant technology innovations to date for clinicians and patients across Europe and the United Kingdom, delivering a transformative leap in image quality and a major expansion of clinical capability for European markets GUILFORD, Conn.
## Recent Company News
- 2026-07-01 12:15 EST — [Hyperfine Announces European Launch of Next-Generation Swoop® System](https://biopharmsignal.com/news/HYPR/hyperfine-announces-european-launch-of-next-generation-swoop-system-eb9cfb69) — Source: Hyperfine
- 2026-06-22 12:15 EST — [Hyperfine Forms Global Neurosurgery Advisory Council to Support Expansion of Portable MRI in Neurosurgical Care](https://biopharmsignal.com/news/HYPR/hyperfine-forms-global-neurosurgery-advisory-council-to-support-expansion-of-por-cc32f725) — Source: Hyperfine
- 2026-06-18 12:15 EST — [Hyperfine Swoop® System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care](https://biopharmsignal.com/news/HYPR/hyperfine-swoop-system-scan-volume-in-the-united-states-hits-record-milestones-a-388aa4d6) — Source: Hyperfine
- 2026-05-26 12:15 EST — [Hyperfine to Join Russell 2000® and Russell 3000® Indexes](https://biopharmsignal.com/news/HYPR/hyperfine-to-join-russell-2000r-and-russell-3000r-indexes) — Source: Hyperfine
- 2026-05-22 12:15 EST — [Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments](https://biopharmsignal.com/news/HYPR/hyperfine-announces-presentation-of-results-from-the-prime-study-showing-portable-mri-substantially-reduces-time-to-imaging-in-emergency-departments) — Source: Hyperfine
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)